PLAY PODCASTS
Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.
Episode 125

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. The assay can help confirm the most-severe stiff-person phenotype — kno

Answers from the Lab

February 22, 202216m 18s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

(0:32):
Before we get started, Dr. McKeon, could you please tell our listeners a little bit about yourself and your background?
 
(01:13)
 How long have you been with the lab? 

(01:37)
 Could you describe which patients should have this testing and when should it be performed? 

(01:50)
 Can you tell us a little bit about this unique assay that has not only glycine receptor but also other antibody tests? 

(03:12)
 We offer this evaluation in both serum and CSF. Can you offer any guidance about when one is more appropriate than the other?

(04:37)
 Four different antibodies are included in the stiff-person assay. Why is it most appropriate to evaluate all four? And why is this assay separate from our movement disorder evaluation that includes 20 different antibodies?

(06:19)
 Is it important to include all relevant antibodies — but not those would lead physicians down a confusing path?

(07:50)
 Can you give our listeners a couple examples of patient presentations that might lead a physician to order this evaluation, and a couple examples where it wouldn't be appropriate?

(09:59)
 Can you give a couple examples of when a broader movement disorder evaluation would be appropriate?

(11:11)
 How does this new stiff-person evaluation improve upon previous approaches? What will this new test offer to physicians?

(12:35)
 What does a positive or negative stiff-person evaluation result mean for a patient's care?

(13:25)
 How do alanine receptor positivity and immune responsiveness affect a patient's prognosis?

(13:58)
 Can tests other than this offering from Mayo Clinic Laboratories give physicians the same answers?

(14:44)
What is the key takeaway about this test?

Topics

laboratory medicinehealthcareanswers from the labmayo clinic laboratorieslabmayo clinicclinicalDLMPMoricePritt